| Pharmaceutical Information |
| Drug Name |
Bromazepam |
| Drug ID |
BADD_D00299 |
| Description |
One of the benzodiazepines that is used in the treatment of anxiety disorders. It is a Schedule IV drug in the U.S. and Canada and under the Convention on Psychotropic Substances. It is a intermediate-acting benzodiazepine. |
| Indications and Usage |
For the short-term treatment of insomnia, short-term treatment of anxiety or panic attacks, if a benzodiazepine is required, and the alleviation of the symptoms of alcohol- and opiate-withdrawal. |
| Marketing Status |
approved; illicit; investigational |
| ATC Code |
N05BA08 |
| DrugBank ID |
DB01558
|
| KEGG ID |
D01245
|
| MeSH ID |
D001960
|
| PubChem ID |
2441
|
| TTD Drug ID |
D0E3FD
|
| NDC Product Code |
Not Available |
| UNII |
X015L14V0O
|
| Synonyms |
Bromazepam | Apo-Bromazepam | Apo Bromazepam | BromaLich | Bromaz 1A Pharma | Bromazanil | Bromazep Von Ct | Von Ct, Bromazep | Bromazepam AL | Bromazepam Beta | Beta, Bromazepam | Bromazepam Heumann | Bromazepam-Neuraxpharm | Bromazepam Neuraxpharm | Bromazepam-Ratiopharm | Bromazepam Ratiopharm | Durazanil | Gen-Bromazepam | Gen Bromazepam | Lexotan | Lexomil | Lexatin | Lexotanil | Ro 5-3350 | Ro 53350 | Anxyrex |
|
| Chemical Information |
| Molecular Formula |
C14H10BrN3O |
| CAS Registry Number |
1812-30-2 |
| SMILES |
C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=N3 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
